Related Experiment Videos
Medication compliance after renal transplantation
L B Hilbrands1, A J Hoitsma, R A Koene
1Department of Medicine, University Hospital Nijmegen, The Netherlands.
Transplantation
|November 15, 1995
Summary
Patient medication compliance after renal transplantation is generally high, though noncompliance with certain immunosuppressive and antihypertensive drugs occurs. Noncompliance is linked to acute rejection episodes, highlighting its importance in transplant outcomes.
Area of Science:
- Nephrology
- Transplantation Immunology
- Pharmacology
Background:
- Noncompliance with immunosuppressive therapy is a significant risk factor for late graft failure in renal transplant recipients.
- Understanding medication adherence patterns is crucial for optimizing long-term transplant success and patient outcomes.
Purpose of the Study:
- To prospectively assess medication compliance rates during the first year post-renal transplantation.
- To investigate the relationship between noncompliance and demographic/clinical variables, including acute rejection episodes.
Main Methods:
- Prospective study involving 127 renal transplant patients in a randomized trial.
- Monthly pill counts were used to determine compliance with immunosuppressive (cyclosporine, azathioprine, prednisone) and antihypertensive (atenolol, nifedipine) drugs.
- Statistical analysis examined correlations between compliance and clinical factors, and compared compliance between treatment groups.
Main Results:
- Overall compliance rates were high, but significant variability was observed. Noncompliance rates varied by drug: cyclosporine (23%), azathioprine (13%), prednisone (23%), atenolol (36%), and nifedipine (32%).
- Compliance with immunosuppressive drugs was significantly better than with antihypertensive medications (P < 0.001).
- Patients experiencing acute rejection episodes showed higher noncompliance, particularly with prednisone (P < 0.01). Compliance improved after rejection events.
Conclusions:
- Noncompliance with immunosuppressive drugs is not a major issue during the first year post-renal transplantation, despite variability.
- Noncompliance, especially with immunosuppressants, likely contributes to a subset of acute rejection episodes.
- Improved adherence was noted following rejection events, suggesting a potential for intervention.